These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 72276)

  • 21. [Conservative treatment of hemarthrosis in hemophiliacs].
    Weseloh G; Seiler G
    Z Orthop Ihre Grenzgeb; 1972 Apr; 110(2):212-5. PubMed ID: 4261880
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL
    Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven.
    Johannessen M; Andreasen RB; Nordfang O
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):239-42. PubMed ID: 10870803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy of a pseudotumor in a hemophiliac with Factor VIII inhibitor.
    Correra A; Buckley J; Roser S; Schreiber A; Syrop S
    Am J Pediatr Hematol Oncol; 1984; 6(3):325-7. PubMed ID: 6440443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life-threatening oro-pharyngeal bleeding in a haemophiliac with factor VIII inhibitors.
    Roderick PJ; Robinson AC
    Clin Lab Haematol; 1988; 10(2):217-9. PubMed ID: 3138066
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of odontogenic large cysts in haemophiliac patients.
    Cakr O; Kazancoğlu HO; Ak G; Zülfikar B
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):253-4. PubMed ID: 22460824
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemophilia, a changed picture].
    Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448
    [No Abstract]   [Full Text] [Related]  

  • 30. Agarose gel method: its usefulness in assaying factor VIII inhibitors, evaluating treatment and suggesting a mechanism of action for factor IX concentrates.
    Coots MC; Glueck HI; Miller MA
    Br J Haematol; 1985 Aug; 60(4):735-50. PubMed ID: 3927972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful operation on a haemophiliac with Factor VIII inhibitor treated by plasmapheresis and Factor VIII infusions.
    Monteagudo J; Puig LL; Lao J; Labal F; Pina F; Maragall S; Gelabert A; Castillo R
    Transfusion; 1985; 25(1):85-6. PubMed ID: 3918365
    [No Abstract]   [Full Text] [Related]  

  • 32. Total dental extraction in a patient with F VIII inhibitor.
    Stenbjerg S; Tauris P; Skottun T; Jørgensen J
    Thromb Res; 1980 Jun; 18(6):889-93. PubMed ID: 6774444
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired hemophilia first manifesting as life-threatening intracranial hemorrhage: case report.
    Mashiko R; Yamamoto T; Sato M; Noguchi S; Matsumura A
    Neurol Med Chir (Tokyo); 2009 Feb; 49(2):93-5. PubMed ID: 19246873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
    Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor products in the treatment of hemophilia.
    Miller KL
    J Pediatr Health Care; 2004; 18(3):156-7. PubMed ID: 15129219
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 37. The safety of pharmacologic options for the treatment of persons with hemophilia.
    Franchini M; Mannucci PM
    Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe hemorrhagic syndrome in a high responder patient with hemophilia A. Value of porcine factor VIII].
    Boullet M; Goudemand J; Smith P; Willot I; Ballestrazzi V
    Ann Fr Anesth Reanim; 1989; 8(3):280-3. PubMed ID: 2506779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of deep soft tissue bleeding and hemarthrosis in hemophilia.
    Miller EH; Flessa HC; Glueck HI
    Clin Orthop Relat Res; 1972; 82():92-107. PubMed ID: 5011042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.